+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Companion Animal Vaccine Market by Animal Type, Vaccine Type, Route of Administration, Distribution Channel - Global Forecast to 2030- Product Image
Companion Animal Vaccine Market by Animal Type, Vaccine Type, Route of Administration, Distribution Channel - Global Forecast to 2030- Product Image
Sale

Companion Animal Vaccine Market by Animal Type, Vaccine Type, Route of Administration, Distribution Channel - Global Forecast to 2030

  • PDF Icon

    Report

  • 199 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5674687
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The companion animal vaccine market is undergoing rapid transformation, shaped by technological progress, evolving regulatory frameworks, and new expectations from pet owners. Senior decision-makers face a complex landscape where innovation and operational resilience determine strategic advantage.

Market Snapshot: Robust Growth in Companion Animal Vaccine Market

The companion animal vaccine market grew from USD 4.97 billion in 2024 to USD 5.39 billion in 2025. It is projected to continue its upward trajectory at a CAGR of 8.26%, reaching USD 8.01 billion by 2030. This growth reflects accelerating investment in new vaccine platforms, unprecedented demand for premium pet care, and the continuous introduction of safe, effective immunization products catering to both established and emerging animal health threats.

Scope & Segmentation

This report delivers an in-depth analysis of the companion animal vaccine market, segmented to ensure comprehensive understanding of both innovation and market demand. The scope encompasses technological advancements, regulatory frameworks, and dynamic geographic trends influencing the industry's evolution.

  • Animal Types: Cats, Dogs
  • Vaccine Types: Inactivated (split cell, whole cell), Live Attenuated, mRNA, Recombinant, Subunit, Toxoid
  • Routes of Administration: Mucosal (nasal, oral), Parenteral (intramuscular, subcutaneous)
  • Distribution Channels: Online (E-Pharmacies, Manufacturer Websites), Pharmacies, Veterinary Clinics, Veterinary Hospitals
  • Geographic Coverage: Americas (including the United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (notably the UK, Germany, France, Russia, Italy, Spain, and others), Asia-Pacific (China, India, Japan, Australia, South Korea, and others)
  • Company Analysis: Strategic insights into global industry leaders including Zoetis, Merck & Co., Elanco, Boehringer Ingelheim, Ceva Santé Animale, Virbac, Vetoquinol, Dechra, Laboratorios Hipra, Animalcare Group, and Esco Healthcare

Key Takeaways: Strategic Insights Shaping Executive Decisions

  • Technological innovation in recombinant and mRNA vaccines is redefining immunization strategies and enabling resilient product pipelines.
  • Customizable vaccination schedules and combination vaccines are becoming market differentiators as owners demand efficiency and tailored protection.
  • Digital platforms are playing a growing role in monitoring vaccination adherence, streamlining supply chains, and facilitating data-driven decision-making across value chains.
  • Regulatory harmonization in major markets is reducing time-to-market for new products, encouraging strategic competition among industry leaders and opening pathways for agile innovators.
  • Market segmentation by animal type, technology, and administration route is critical for resource allocation and identifying growth opportunities in underserved geographies and channels.
  • Regional market development hinges on the ability to adapt to varying regulatory environments, infrastructure maturity, and local owner preferences.

Tariff Impact: Navigating Cost Pressures and Supply Chain Realignment

The 2025 adjustments to US tariffs have increased input costs and compelled companies to reexamine procurement, manufacturing, and logistics strategies. Manufacturers are now prioritizing domestic sourcing and vertical integration to manage exposure, while efficiency drives collaboration with contract organizations and the adoption of automation. These shifts have further influenced downstream pricing, prompting new approaches such as value-based models and strategic logistics partnerships to maintain profitability and ensure timely product delivery in a challenging trade environment.

Methodology & Data Sources

The report applies mixed-methods research, combining primary interviews with industry stakeholders and extensive secondary analysis of regulatory filings, scientific literature, and market data. Triangulation techniques validate each data point, while segmentation and regional insights are rigorously benchmarked and peer-reviewed by subject-matter experts across veterinary immunology and market economics.

Why This Report Matters

  • Enables executives to make confident, data-backed investments in technology, supply chain resilience, and strategic partnerships.
  • Provides nuanced visibility into regional and segment-specific opportunities aligned with evolving customer expectations and regulatory demands.
  • Equips decision-makers with actionable intelligence for navigating disruption and capturing value in a rapidly changing companion animal vaccine landscape.

Conclusion

Continued innovation, regulatory agility, and robust supply chain strategies are redefining leadership in the companion animal vaccine sector. As the market evolves, organizations equipped with data-driven insights and adaptive strategies will be best positioned for sustainable growth and competitive resilience.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Companion Animal Vaccine Market, by Animal Type
8.1. Introduction
8.2. Cats
8.3. Dogs
9. Companion Animal Vaccine Market, by Vaccine Type
9.1. Introduction
9.2. Inactivated
9.2.1. Split Cell
9.2.2. Whole Cell
9.3. Live Attenuated
9.4. mRNA
9.5. Recombinant
9.6. Subunit
9.7. Toxoid
10. Companion Animal Vaccine Market, by Route of Administration
10.1. Introduction
10.2. Mucosal
10.2.1. Nasal
10.2.2. Oral
10.3. Parenteral
10.3.1. Intramuscular
10.3.2. Subcutaneous
11. Companion Animal Vaccine Market, by Distribution Channel
11.1. Introduction
11.2. Online
11.2.1. E Pharmacies
11.2.2. Manufacturer Websites
11.3. Pharmacies
11.4. Veterinary Clinics
11.5. Veterinary Hospitals
12. Americas Companion Animal Vaccine Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Companion Animal Vaccine Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Companion Animal Vaccine Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Zoetis Inc.
15.3.2. Merck & Co., Inc.
15.3.3. Elanco Animal Health Incorporated
15.3.4. Boehringer Ingelheim International GmbH
15.3.5. Ceva Santé Animale S.A.
15.3.6. Virbac S.A.
15.3.7. Vetoquinol S.A.
15.3.8. Dechra Pharmaceuticals PLC
15.3.9. Laboratorios Hipra, S.A.
15.3.10. Animalcare Group PLC
15.3.11. Esco Healthcare
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. COMPANION ANIMAL VACCINE MARKET MULTI-CURRENCY
FIGURE 2. COMPANION ANIMAL VACCINE MARKET MULTI-LANGUAGE
FIGURE 3. COMPANION ANIMAL VACCINE MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS COMPANION ANIMAL VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS COMPANION ANIMAL VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES COMPANION ANIMAL VACCINE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES COMPANION ANIMAL VACCINE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC COMPANION ANIMAL VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC COMPANION ANIMAL VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. COMPANION ANIMAL VACCINE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. COMPANION ANIMAL VACCINE MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. COMPANION ANIMAL VACCINE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY CATS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY DOGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY INACTIVATED, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY SPLIT CELL, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY WHOLE CELL, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY INACTIVATED, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY LIVE ATTENUATED, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY MRNA, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY RECOMBINANT, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY SUBUNIT, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY TOXOID, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY MUCOSAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY NASAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY MUCOSAL, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY E PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY MANUFACTURER WEBSITES, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY VETERINARY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS COMPANION ANIMAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS COMPANION ANIMAL VACCINE MARKET SIZE, BY INACTIVATED, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS COMPANION ANIMAL VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS COMPANION ANIMAL VACCINE MARKET SIZE, BY MUCOSAL, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS COMPANION ANIMAL VACCINE MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS COMPANION ANIMAL VACCINE MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS COMPANION ANIMAL VACCINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES COMPANION ANIMAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES COMPANION ANIMAL VACCINE MARKET SIZE, BY INACTIVATED, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES COMPANION ANIMAL VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES COMPANION ANIMAL VACCINE MARKET SIZE, BY MUCOSAL, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES COMPANION ANIMAL VACCINE MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES COMPANION ANIMAL VACCINE MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES COMPANION ANIMAL VACCINE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 54. CANADA COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 55. CANADA COMPANION ANIMAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 56. CANADA COMPANION ANIMAL VACCINE MARKET SIZE, BY INACTIVATED, 2018-2030 (USD MILLION)
TABLE 57. CANADA COMPANION ANIMAL VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 58. CANADA COMPANION ANIMAL VACCINE MARKET SIZE, BY MUCOSAL, 2018-2030 (USD MILLION)
TABLE 59. CANADA COMPANION ANIMAL VACCINE MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 60. CANADA COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 61. CANADA COMPANION ANIMAL VACCINE MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 62. MEXICO COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 63. MEXICO COMPANION ANIMAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 64. MEXICO COMPANION ANIMAL VACCINE MARKET SIZE, BY INACTIVATED, 2018-2030 (USD MILLION)
TABLE 65. MEXICO COMPANION ANIMAL VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 66. MEXICO COMPANION ANIMAL VACCINE MARKET SIZE, BY MUCOSAL, 2018-2030 (USD MILLION)
TABLE 67. MEXICO COMPANION ANIMAL VACCINE MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 68. MEXICO COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 69. MEXICO COMPANION ANIMAL VACCINE MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 70. BRAZIL COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 71. BRAZIL COMPANION ANIMAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 72. BRAZIL COMPANION ANIMAL VACCINE MARKET SIZE, BY INACTIVATED, 2018-2030 (USD MILLION)
TABLE 73. BRAZIL COMPANION ANIMAL VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 74. BRAZIL COMPANION ANIMAL VACCINE MARKET SIZE, BY MUCOSAL, 2018-2030 (USD MILLION)
TABLE 75. BRAZIL COMPANION ANIMAL VACCINE MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 76. BRAZIL COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 77. BRAZIL COMPANION ANIMAL VACCINE MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 78. ARGENTINA COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 79. ARGENTINA COMPANION ANIMAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 80. ARGENTINA COMPANION ANIMAL VACCINE MARKET SIZE, BY INACTIVATED, 2018-2030 (USD MILLION)
TABLE 81. ARGENTINA COMPANION ANIMAL VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 82. ARGENTINA COMPANION ANIMAL VACCINE MARKET SIZE, BY MUCOSAL, 2018-2030 (USD MILLION)
TABLE 83. ARGENTINA COMPANION ANIMAL VACCINE MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 84. ARGENTINA COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 85. ARGENTINA COMPANION ANIMAL VACCINE MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 86. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 87. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 88. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL VACCINE MARKET SIZE, BY INACTIVATED, 2018-2030 (USD MILLION)
TABLE 89. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 90. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL VACCINE MARKET SIZE, BY MUCOSAL, 2018-2030 (USD MILLION)
TABLE 91. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL VACCINE MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 92. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 93. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL VACCINE MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 94. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL VACCINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 95. UNITED KINGDOM COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 96. UNITED KINGDOM COMPANION ANIMAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 97. UNITED KINGDOM COMPANION ANIMAL VACCINE MARKET SIZE, BY INACTIVATED, 2018-2030 (USD MILLION)
TABLE 98. UNITED KINGDOM COMPANION ANIMAL VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 99. UNITED KINGDOM COMPANION ANIMAL VACCINE MARKET SIZE, BY MUCOSAL, 2018-2030 (USD MILLION)
TABLE 100. UNITED KINGDOM COMPANION ANIMAL VACCINE MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 101. UNITED KINGDOM COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 102. UNITED KINGDOM COMPANION ANIMAL VACCINE MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 103. GERMANY COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 104. GERMANY COMPANION ANIMAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 105. GERMANY COMPANION ANIMAL VACCINE MARKET SIZE, BY INACTIVATED, 2018-2030 (USD MILLION)
TABLE 106. GERMANY COMPANION ANIMAL VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 107. GERMANY COMPANION ANIMAL VACCINE MARKET SIZE, BY MUCOSAL, 2018-2030 (USD MILLION)
TABLE 108. GERMANY COMPANION ANIMAL VACCINE MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 109. GERMANY COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 110. GERMANY COMPANION ANIMAL VACCINE MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 111. FRANCE COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 112. FRANCE COMPANION ANIMAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 113. FRANCE COMPANION ANIMAL VACCINE MARKET SIZE, BY INACTIVATED, 2018-2030 (USD MILLION)
TABLE 114. FRANCE COMPANION ANIMAL VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 115. FRANCE COMPANION ANIMAL VACCINE MARKET SIZE, BY MUCOSAL, 2018-2030 (USD MILLION)
TABLE 116. FRANCE COMPANION ANIMAL VACCINE MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 117. FRANCE COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 118. FRANCE COMPANION ANIMAL VACCINE MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 119. RUSSIA COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 120. RUSSIA COMPANION ANIMAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 121. RUSSIA COMPANION ANIMAL VACCINE MARKET SIZE, BY INACTIVATED, 2018-2030 (USD MILLION)
TABLE 122. RUSSIA COMPANION ANIMAL VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 123. RUSSIA COMPANION ANIMAL VACCINE MARKET SIZE, BY MUCOSAL, 2018-2030 (USD MILLION)
TABLE 124. RUSSIA COMPANION ANIMAL VACCINE MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 125. RUSSIA COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 126. RUSSIA COMPANION ANIMAL VACCINE MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 127. ITALY COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 128. ITALY COMPANION ANIMAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 129. ITALY COMPANION ANIMAL VACCINE MARKET SIZE, BY INACTIVATED, 2018-2030 (USD MILLION)
TABLE 130. ITALY COMPANION ANIMAL VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 131. ITALY COMPANION ANIMAL VACCINE MARKET SIZE, BY MUCOSAL, 2018-2030 (USD MILLION)
TABLE 132. ITALY COMPANION ANIMAL VACCINE MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 133. ITALY COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 134. ITALY COMPANION ANIMAL VACCINE MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 135. SPAIN COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 136. SPAIN COMPANION ANIMAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 137. SPAIN COMPANION ANIMAL VACCINE MARKET SIZE, BY INACTIVATED, 2018-2030 (USD MILLION)
TABLE 138. SPAIN COMPANION ANIMAL VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 139. SPAIN COMPANION ANIMAL VACCINE MARKET SIZE, BY MUCOSAL, 2018-2030 (USD MILLION)
TABLE 140. SPAIN COMPANION ANIMAL VACCINE MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 141. SPAIN COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 142. SPAIN COMPANION ANIMAL VACCINE MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 143. UNITED ARAB EMIRATES COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 144. UNITED ARAB EMIRATES COMPANION ANIMAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 145. UNITED ARAB EMIRATES COMPANION ANIMAL VACCINE MARKET SIZE, BY INACTIVATED, 2018-2030 (USD MILLION)
TABLE 146. UNITED ARAB EMIRATES COMPANION ANIMAL VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 147. UNITED ARAB EMIRATES COMPANION ANIMAL VACCINE MARKET SIZE, BY MUCOSAL, 2018-2030 (USD MILLION)
TABLE 148. UNITED ARAB EMIRATES COMPANION ANIMAL VACCINE MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 149. UNITED ARAB EMIRATES COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 150. UNITED ARAB EMIRATES COMPANION ANIMAL VACCINE MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 151. SAUDI ARABIA COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 152. SAUDI ARABIA COMPANION ANIMAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 153. SAUDI ARABIA COMPANION ANIMAL VACCINE MARKET SIZE, BY INACTIVATED, 2018-2030 (USD MILLION)
TABLE 154. SAUDI ARABIA COMPANION ANIMAL VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 155. SAUDI ARABIA COMPANION ANIMAL VACCINE MARKET SIZE, BY MUCOSAL, 2018-2030 (USD MILLION)
TABLE 156. SAUDI ARABIA COMPANION ANIMAL VACCINE MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 157. SAUDI ARABIA COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 158. SAUDI ARABIA COMPANION ANIMAL VACCINE MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 159. SOUTH AFRICA COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 160. SOUTH AFRICA COMPANION ANIMAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 161. SOUTH AFRICA COMPANION ANIMAL VACCINE MARKET SIZE, BY INACTIVATED, 2018-2030 (USD MILLION)
TABLE 162. SOUTH AFRICA COMPANION ANIMAL VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 163. SOUTH AFRICA COMPANION ANIMAL VACCINE MARKET SIZE, BY MUCOSAL, 2018-2030 (USD MILLION)
TABLE 164. SOUTH AFRICA COMPANION ANIMAL VACCINE MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 165. SOUTH AFRICA COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 166. SOUTH AFRICA COMPANION ANIMAL VACCINE MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 167. DENMARK COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 168. DENMARK COMPANION ANIMAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 169. DENMARK COMPANION ANIMAL VACCINE MARKET SIZE, BY INACTIVATED, 2018-2030 (USD MILLION)
TABLE 170. DENMARK COMPANION ANIMAL VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 171. DENMARK COMPANION ANIMAL VACCINE MARKET SIZE, BY MUCOSAL, 2018-2030 (USD MILLION)
TABLE 172. DENMARK COMPANION ANIMAL VACCINE MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 173. DENMARK COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 174. DENMARK COMPANION ANIMAL VACCINE MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 175. NETHERLANDS COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 176. NETHERLANDS COMPANION ANIMAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 177. NETHERLANDS COMPANION ANIMAL VACCINE MARKET SIZE, BY INACTIVATED, 2018-2030 (USD MILLION)
TABLE 178. NETHERLANDS COMPANION ANIMAL VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 179. NETHERLANDS COMPANION ANIMAL VACCINE MARKET SIZE, BY MUCOSAL, 2018-2030 (USD MILLION)
TABLE 180. NETHERLANDS COMPANION ANIMAL VACCINE MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 181. NETHERLANDS COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 182. NETHERLANDS COMPANION ANIMAL VACCINE MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 183. QATAR COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 184. QATAR COMPANION ANIMAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 185. QATAR COMPANION ANIMAL VACCINE MARKET SIZE, BY INACTIVATED, 2018-2030 (USD MILLION)
TABLE 186. QATAR COMPANION ANIMAL VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 187. QATAR COMPANION ANIMAL VACCINE MARKET SIZE, BY MUCOSAL, 2018-2030 (USD MILLION)
TABLE 188. QATAR COMPANION ANIMAL VACCINE MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 189. QATAR COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 190. QATAR COMPANION ANIMAL VACCINE MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 191. FINLAND COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 192. FINLAND COMPANION ANIMAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 193. FINLAND COMPANION ANIMAL VACCINE MARKET SIZE, BY INACTIVATED, 2018-2030 (USD MILLION)
TABLE 194. FINLAND COMPANION ANIMAL VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 195. FINLAND COMPANION ANIMAL VACCINE MARKET SIZE, BY MUCOSAL, 2018-2030 (USD MILLION)
TABLE 196. FINLAND COMPANION ANIMAL VACCINE MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 197. FINLAND COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 198. FINLAND COMPANION ANIMAL VACCINE MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 199. SWEDEN COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 200. SWEDEN COMPANION ANIMAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 201. SWEDEN COMPANION ANIMAL VACCINE MARKET SIZE, BY INACTIVATED, 2018-2030 (USD MILLION)
TABLE 202. SWEDEN COMPANION ANIMAL VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 203. SWEDEN COMPANION ANIMAL VACCINE MARKET SIZE, BY MUCOSAL, 2018-2030 (USD MILLION)
TABLE 204. SWEDEN COMPANION ANIMAL VACCINE MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 205. SWEDEN COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 206. SWEDEN COMPANION ANIMAL VACCINE MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 207. NIGERIA COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 208. NIGERIA COMPANION ANIMAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 209. NIGERIA COMPANION ANIMAL VACCINE MARKET SIZE, BY INACTIVATED, 2018-2030 (USD MILLION)
TABLE 210. NIGERIA COMPANION ANIMAL VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 211. NIGERIA COMPANION ANIMAL VACCINE MARKET SIZE, BY MUCOSAL, 2018-2030 (USD MILLION)
TABLE 212. NIGERIA COMPANION ANIMAL VACCINE MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 213. NIGERIA COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 214. NIGERIA COMPANION ANIMAL VACCINE MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 215. EGYPT COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 216. EGYPT COMPANION ANIMAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 217. EGYPT COMPANION ANIMAL VACCINE MARKET SIZE, BY INACTIVATED, 2018-2030 (USD MILLION)
TABLE 218. EGYPT COMPANION ANIMAL VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 219. EGYPT COMPANION ANIMAL VACCINE MARKET SIZE, BY MUCOSAL, 2018-2030 (USD MILLION)
TABLE 220. EGYPT COMPANION ANIMAL VACCINE MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 221. EGYPT COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 222. EGYPT COMPANION ANIMAL VACCINE MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 223. TURKEY COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 224. TURKEY COMPANION ANIMAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 225. TURKEY COMPANION ANIMAL VACCINE MARKET SIZE, BY INACTIVATED, 2018-2030 (USD MILLION)
TABLE 226. TURKEY COMPANION ANIMAL VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 227. TURKEY COMPANION ANIMAL VACCINE MARKET SIZE, BY MUCOSAL, 2018-2030 (USD MILLION)
TABLE 228. TURKEY COMPANION ANIMAL VACCINE MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 229. TURKEY COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 230. TURKEY COMPANION ANIMAL VACCINE MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 231. ISRAEL COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 232. ISRAEL COMPANION ANIMAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 233. ISRAEL COMPANION ANIMAL VACCINE MARKET SIZE, BY INACTIVATED, 2018-2030 (USD MILLION)
TABLE 234. ISRAEL COMPANION ANIMAL VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 235. ISRAEL COMPANION ANIMAL VACCINE MARKET SIZE, BY MUCOSAL, 2018-2030 (USD MILLION)
TABLE 236. ISRAEL COMPANION ANIMAL VACCINE MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 237. ISRAEL COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 238. ISRAEL COMPANION ANIMAL VACCINE MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 239. NORWAY COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 240. NORWAY COMPANION ANIMAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 241. NORWAY COMPANION ANIMAL VACCINE MARKET SIZE, BY INACTIVATED, 2018-2030 (USD MILLION)
TABLE 242. NORWAY COMPANION ANIMAL VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 243. NORWAY COMPANION ANIMAL VACCINE MARKET SIZE, BY MUCOSAL, 2018-2030 (USD MILLION)
TABLE 244. NORWAY COMPANION ANIMAL VACCINE MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 245. NORWAY COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 246. NORWAY COMPANION ANIMAL VACCINE MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 247. POLAND COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 248. POLAND COMPANION ANIMAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 249. POLAND COMPANION ANIMAL VACCINE MARKET SIZE, BY INACTIVATED, 2018-2030 (USD MILLION)
TABLE 250. POLAND COMPANION ANIMAL VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 251. POLAND COMPANION ANIMAL VACCINE MARKET SIZE, BY MUCOSAL, 2018-2030 (USD MILLION)
TABLE 252. POLAND COMPANION ANIMAL VACCINE MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 253. POLAND COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 254. POLAND COMPANION ANIMAL VACCINE MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 255. SWITZERLAND COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 256. SWITZERLAND COMPANION ANIMAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 257. SWITZERLAND COMPANION ANIMAL VACCINE MARKET SIZE, BY INACTIVATED, 2018-2030 (USD MILLION)
TABLE 258. SWITZERLAND COMPANION ANIMAL VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 259. SWITZERLAND COMPANION ANIMAL VACCINE MARKET SIZE, BY MUCOSAL, 2018-2030 (USD MILLION)
TABLE 260. SWITZERLAND COMPANION ANIMAL VACCINE MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 261. SWITZERLAND COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 262. SWITZERLAND COMPANION ANIMAL VACCINE MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 263. ASIA-PACIFIC COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 264. ASIA-PACIFIC COMPANION ANIMAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 265. ASIA-PACIFIC COMPANION ANIMAL VACCINE MARKET SIZE, BY INACTIVATED, 2018-2030 (USD MILLION)
TABLE 266. ASIA-PACIFIC COMPANION ANIMAL VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 267. ASIA-PACIFIC COMPANION ANIMAL VACCINE MARKET SIZE, BY MUCOSAL, 2018-2030 (USD MILLION)
TABLE 268. ASIA-PACIFIC COMPANION ANIMAL VACCINE MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 269. ASIA-PACIFIC COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 270. ASIA-PACIFIC COMPANION ANIMAL VACCINE MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 271. ASIA-PACIFIC COMPANION ANIMAL VACCINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 272. CHINA COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 273. CHINA COMPANION ANIMAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 274. CHINA COMPANION ANIMAL VACCINE MARKET SIZE, BY INACTIVATED, 2018-2030 (USD MILLION)
TABLE 275. CHINA COMPANION ANIMAL VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 276. CHINA COMPANION ANIMAL VACCINE MARKET SIZE, BY MUCOSAL, 2018-2030 (USD MILLION)
TABLE 277. CHINA COMPANION ANIMAL VACCINE MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 278. CHINA COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 279. CHINA COMPANION ANIMAL VACCINE MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 280. INDIA COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 281. INDIA COMPANION ANIMAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 282. INDIA COMPANION ANIMAL VACCINE MARKET SIZE, BY INACTIVATED, 2018-2030 (USD MILLION)
TABLE 283. INDIA COMPANION ANIMAL VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 284. INDIA COMPANION ANIMAL VACCINE MARKET SIZE, BY MUCOSAL, 2018-2030 (USD MILLION)
TABLE 285. INDIA COMPANION ANIMAL VACCINE MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 286. INDIA COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 287. INDIA COMPANION ANIMAL VACCINE MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 288. JAPAN COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 289. JAPAN COMPANION ANIMAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 290. JAPAN COMPANION ANIMAL VACCINE MARKET SIZE, BY INACTIVATED, 2018-2030 (USD MILLION)
TABLE 291. JAPAN COMPANION ANIMAL VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 292. JAPAN COMPANION ANIMAL VACCINE MARKET SIZE, BY MUCOSAL, 2018-2030 (USD MILLION)
TABLE 293. JAPAN COMPANION ANIMAL VACCINE MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 294. JAPAN COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 295. JAPAN COMPANION ANIMAL VACCINE MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 296. AUSTRALIA COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 297. AUSTRALIA COMPANION ANIMAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 298. AUSTRALIA COMPANION ANIMAL VACCINE MARKET SIZE, BY INACTIVATED, 2018-2030 (USD MILLION)
TABLE 299. AUSTRALIA COMPANION ANIMAL VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 300. AUSTRALIA COMPANION ANIMAL VACCINE MARKET SIZE, BY MUCOSAL, 2018-2030 (USD MILLION)
TABLE 301. AUSTRALIA COMPANION ANIMAL VACCINE MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 302. AUSTRALIA COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 303. AUSTRALIA COMPANION ANIMAL VACCINE MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 304. SOUTH KOREA COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 305. SOUTH KOREA COMPANION ANIMAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 306. SOUTH KOREA COMPANION ANIMAL VACCINE MARKET SIZE, BY INACTIVATED, 2018-2030 (USD MILLION)
TABLE 307. SOUTH KOREA COMPANION ANIMAL VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 308. SOUTH KOREA COMPANION ANIMAL VACCINE MARKET SIZE, BY MUCOSAL, 2018-2030 (USD MILLION)
TABLE 309. SOUTH KOREA COMPANION ANIMAL VACCINE MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 310. SOUTH KOREA COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 311. SOUTH KOREA COMPANION ANIMAL VACCINE MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 312. INDONESIA COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 313. INDONESIA COMPANION ANIMAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 314. INDONESIA COMPANION ANIMAL VACCINE MARKET SIZE, BY INACTIVATED, 2018-2030 (USD MILLION)
TABLE 315. INDONESIA COMPANION ANIMAL VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 316. INDONESIA COMPANION ANIMAL VACCINE MARKET SIZE, BY MUCOSAL, 2018-2030 (USD MILLION)
TABLE 317. INDONESIA COMPANION ANIMAL VACCINE MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 318. INDONESIA COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 319. INDONESIA COMPANION ANIMAL VACCINE MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 320. THAILAND COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 321. THAILAND COMPANION ANIMAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 322. THAILAND COMPANION ANIMAL VACCINE MARKET SIZE, BY INACTIVATED, 2018-2030 (USD MILLION)
TABLE 323. THAILAND COMPANION ANIMAL VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 324. THAILAND COMPANION ANIMAL VACCINE MARKET SIZE, BY MUCOSAL, 2018-2030 (USD MILLION)
TABLE 325. THAILAND COMPANION ANIMAL VACCINE MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 326. THAILAND COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 327. THAILAND COMPANION ANIMAL VACCINE MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 328. PHILIPPINES COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 329. PHILIPPINES COMPANION ANIMA

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Companion Animal Vaccine market report include:
  • Zoetis Inc.
  • Merck & Co., Inc.
  • Elanco Animal Health Incorporated
  • Boehringer Ingelheim International GmbH
  • Ceva Santé Animale S.A.
  • Virbac S.A.
  • Vetoquinol S.A.
  • Dechra Pharmaceuticals PLC
  • Laboratorios Hipra, S.A.
  • Animalcare Group PLC
  • Esco Healthcare

Table Information

Report AttributeDetails
No. of Pages199
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 5.39 Billion
Forecasted Market Value ( USD ) by 2030 $ 8.01 Billion
Compound Annual Growth Rate8.2%
Regions CoveredGlobal
No. of Companies Mentioned12

Related Topics

Related Reports

Veterinary Vaccines Market by Product Type, Animal Type, Route Of Administration, Disease Type, Distribution Channel - Global Forecast to 2030 - Product Image

Veterinary Vaccines Market by Product Type, Animal Type, Route Of Administration, Disease Type, Distribution Channel - Global Forecast to 2030

  • Report
  • 189 Pages
  • Global
From
Companion Animal Vaccines Market Size, Share & Trends Analysis Report by Animal Type (Canine, Feline), Product, Route of Administration, Distribution Channel, Product, Region, with Growth Forecasts, 2025-2030 - Product Image

Companion Animal Vaccines Market Size, Share & Trends Analysis Report by Animal Type (Canine, Feline), Product, Route of Administration, Distribution Channel, Product, Region, with Growth Forecasts, 2025-2030

  • Report
  • 150 Pages
  • Global
From
Veterinary/Animal Vaccines Market by Animal Type, Vaccine Technology, Disease Type, Route Of Administration, End User - Global Forecast to 2030 - Product Image

Veterinary/Animal Vaccines Market by Animal Type, Vaccine Technology, Disease Type, Route Of Administration, End User - Global Forecast to 2030

  • Report
  • 183 Pages
  • Global
From
Animal Vaccines Market Size, Share & Trends Analysis Report By Animal Type (Livestock, Companion), By Product, By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Animal Vaccines Market Size, Share & Trends Analysis Report By Animal Type (Livestock, Companion), By Product, By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 150 Pages
  • Global
From
Companion Animal Vaccines - Global Strategic Business Report - Product Image

Companion Animal Vaccines - Global Strategic Business Report

  • Report
  • 473 Pages
  • Global
From

About the Companion Animal Vaccine Market

Within the realm of animal healthcare and veterinary medicine, the Companion Animal Vaccine market is an essential segment focused on the immunization of pets, such as dogs, cats, and horses, against various infectious diseases. This sector addresses the preventative healthcare needs of companion animals by providing a variety of vaccines that target illnesses such as rabies, distemper, parvovirus, and feline leukemia, among others. The availability and development of these vaccines are driven by continuous scientific research, technological advancements, and an increasing awareness among pet owners about the importance of preventative care. Moreover, this market is influenced by regulatory frameworks and animal welfare organizations advocating for the health and safety of companion animals. The administration of vaccines is a critical component of routine veterinary care, aiming to ensure the longevity and quality of life of pets, whilst also aiding in the control of disease outbreaks that could potentially affect human populations as well. Prominent players in the companion animal vaccine market include Zoetis, Merck Animal Health (known as MSD Animal Health outside the United States and Canada), Boehringer Ingelheim, Elanco, Virbac, Vetoquinol, and Ceva Santé Animale. These companies are noteworthy for their extensive research and development efforts, comprehensive vaccine portfolios, and substantial contributions to veterinary medicine and overall animal health. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.